Sanofi announced that the U.S. FDA granted tentative approval for Admelog® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin...
Read moreGenentech, a member of the Roche Group , announced that the U.S. FDA has accepted the company’s supplemental Biologics License...
Read moreAurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the U.S. FDA under the...
Read moreRitter Pharmaceuticals, a developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced...
Read moreAurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug...
Read moreMitsubishi Tanabe Pharma America, Inc. announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis...
Read moreSamumed announced that the U.S. FDA has granted SM04646, a novel small molecule Wnt pathway inhibitor, an Orphan Drug Designation...
Read moreThe Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) of the FDA, has invited PharmaMar to participate in this ODAC,...
Read moreTakeda Pharmaceutical Company Limited announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA)...
Read moreRoche announced that new data on OCREVUS™ in people with relapsing forms of multiple sclerosis (RMS) and primary progressive MS...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.